id: cardiometabolic_risk_factors_to_all_cause_mortality
name: Cardiometabolic Risk Factors â†’ All-Cause Mortality
from_node:
  node_id: cardiometabolic_risk_factors
  node_name: Cardiometabolic Risk Factors
to_node:
  node_id: all_cause_mortality
  node_name: All-Cause Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Presence of cardiometabolic risk factors (obesity, type 2 diabetes, hypertension)
  creates systemic metabolic dysfunction'
- 'Step 2: Metabolic dysfunction contributes to hepatic steatosis and progression
  of liver disease'
- 'Step 3: Combined burden of cardiometabolic conditions and liver disease increases
  overall mortality risk through cardiovascular events, liver-related complications,
  and metabolic sequelae'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Zobair M Younossi et al. 2024. "Clinical profiles and mortality
    rates are similar for metabolic dysfunction-associated steatotic liver disease
    and non-alcoholic fatty liver disease.." *Journal of hepatology*. https://doi.org/10.1016/j.jhep.2024.01.014
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.620597'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: age
  direction: strengthens
  strength: moderate
  description: MASLD individuals were older than NAFLD-only individuals, contributing
    to slightly higher mortality risk
- name: number_of_cardiometabolic_factors
  direction: strengthens
  strength: moderate
  description: 82.51% of participants had at least one cardiometabolic criterion,
    with presence of multiple factors likely increasing mortality risk
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/cardiometabolic_risk_factors_to_all_cause_mortality.yaml
_category: biological
